CHEMTURA CORP's ticker is CHMT and the CUSIP is 163893209. A total of 157 filers reported holding CHEMTURA CORP in Q2 2013. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,607,000 | -1.4% | 108,005 | -2.0% | 0.00% | 0.0% |
| Q4 2016 | $3,659,000 | -4.0% | 110,205 | -5.2% | 0.00% | 0.0% |
| Q3 2016 | $3,813,000 | +31.2% | 116,205 | +5.4% | 0.00% | 0.0% |
| Q2 2016 | $2,907,000 | -11.6% | 110,205 | -11.6% | 0.00% | 0.0% |
| Q1 2016 | $3,290,000 | -3.2% | 124,605 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,398,000 | -5.5% | 124,605 | -0.8% | 0.00% | 0.0% |
| Q3 2015 | $3,595,000 | -2.6% | 125,605 | -3.7% | 0.00% | 0.0% |
| Q2 2015 | $3,692,000 | -8.0% | 130,425 | -11.4% | 0.00% | 0.0% |
| Q1 2015 | $4,015,000 | -10.7% | 147,125 | -19.1% | 0.00% | -25.0% |
| Q4 2014 | $4,496,000 | +4.0% | 181,800 | -1.8% | 0.00% | 0.0% |
| Q3 2014 | $4,321,000 | -18.1% | 185,200 | -8.3% | 0.00% | 0.0% |
| Q2 2014 | $5,278,000 | +3.3% | 202,000 | -0.0% | 0.00% | 0.0% |
| Q1 2014 | $5,109,000 | -92.3% | 202,001 | -91.6% | 0.00% | -93.3% |
| Q4 2013 | $66,763,000 | -8.9% | 2,391,231 | -25.0% | 0.06% | -16.7% |
| Q3 2013 | $73,298,000 | +11.6% | 3,188,247 | -1.4% | 0.07% | +2.9% |
| Q2 2013 | $65,655,000 | – | 3,234,229 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CYRUS CAPITAL PARTNERS, L.P. | 2,089,464 | $48,747,000 | 6.50% |
| RESTRUCTURING CAPITAL ASSOCIATES LP | 338,080 | $7,887,000 | 5.78% |
| Paradice Investment Management LLC | 835,850 | $19,500,000 | 5.07% |
| ROCKSHELTER CAPITAL MANAGEMENT LLC | 782,320 | $18,252,000 | 4.89% |
| Sandhill Capital Partners LLC | 405,261 | $9,455,000 | 3.37% |
| Clearline Capital LP | 880,639 | $20,545,000 | 3.31% |
| WS MANAGEMENT LLLP | 4,338,935 | $101,227,000 | 3.25% |
| Corsair Capital Management | 2,250,976 | $52,516,000 | 2.70% |
| LionEye Capital Management LLC | 1,400,000 | $32,662,000 | 1.79% |
| Tahithromos, L.L.C. | 277,999 | $6,486,000 | 1.68% |